Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mithra Pharmaceuticals SA (BR: MITRA)

 
MITRA Technical Analysis
5
As on 19th Sep 2024 MITRA STOCK Price closed @ 0.22 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.67 & Strong Sell for SHORT-TERM with Stoploss of 2.47 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MITRASTOCK Price

Open 0.22 Change Price %
High 0.22 1 Day 0.00 0.00
Low 0.22 1 Week 0.00 0.00
Close 0.22 1 Month 0.00 0.00
Volume N/A 1 Year -2.80 -92.72
52 Week High 3.06 | 52 Week Low 0.20
 
BR Belgium Most Active Stocks
SCHD 27.59 -91.89%
ABI 57.36 0.60%
BOTHE 0.29 70.59%
UMI 8.40 -1.98%
PROX 6.53 0.46%
ACPH 0.89 0.00%
OPTI 0.01 %
WDP 21.70 1.97%
BPOST 1.37 -2.14%
UCB 181.00 6.88%
 
BR Belgium Top Gainers Stocks
BOTHE 0.29 70.59%
AGFB 0.89 14.10%
CAMB 168.00 12.00%
CAMB 168.00 12.00%
UCB 181.00 6.88%
SOFT 1.00 6.38%
SOFT 1.00 6.38%
TUB 137.20 6.19%
TUB 137.20 6.19%
TUB 137.20 6.19%
 
BR Belgium Top Losers Stocks
SCHD 27.59 -91.89%
BELR 1.93 -74.27%
BELR 1.93 -74.27%
NEWT 1.80 -9.55%
NEWT 1.80 -9.55%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
PIC 66.00 -6.25%
ZEN 185.00 -4.64%
ZEN 185.00 -4.64%
 
 
MITRA
Daily Charts		 MITRA
Intraday Charts		 Whats New @
Bazaartrend		 MITRA
Free Analysis
 
MITRA Important Levels Intraday
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
RESISTANCE0.22
 
MITRA Forecast March 2025
Share
4th UP Forecast1.57
3rd UP Forecast1.14
2nd UP Forecast0.87
1st UP Forecast0.6
1st DOWN Forecast-0.16
2nd DOWN Forecast-0.43
3rd DOWN Forecast-0.7
4th DOWN Forecast-1.13
 
MITRA Weekly Forecast
4th UP Forecast1.07
3rd UP Forecast0.80
2nd UP Forecast0.63
1st UP Forecast0.46
1st DOWN Forecast-0.02
2nd DOWN Forecast-0.19
3rd DOWN Forecast-0.36
4th DOWN Forecast-0.63
 
MITRA Forecast2025
4th UP Forecast7.29
3rd UP Forecast5.02
2nd UP Forecast3.62
1st UP Forecast2.22
1st DOWN Forecast-1.78
2nd DOWN Forecast-3.18
3rd DOWN Forecast-4.58
4th DOWN Forecast-6.85
 
 
MITRA Other Details
Segment EQ
Market Capital 831879680.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
MITRA Address
MITRA
 
MITRA Latest News
 
Your Comments and Response on Mithra Pharmaceuticals SA
 
MITRA Business Profile
Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for vasomotor menopausal symptoms relief; and PeriNesta, an oral treatment for perimenopause. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium. Address: Rue Saint-Georges 5, Liège, Belgium, 4000
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service